What we know about ‘most favored nation’; GSK’s $1.2B MASH deal; Bayer details staff cuts; and more

Happy Saturday and welcome back to Endpoints Weekly! We had a flurry of news this week, so let’s dive in. Our team has the latest news and analysis around the Trump administration’s executive order intended ...

Related Posts

Lilly shuffles key executive positions; Mikael Dolsten ...

May 9, 2025  0

Corvus' Phase 1 atopic dermatitis data prompt stock rally

May 9, 2025  0

Takeda announces handful of pipeline cuts in effort to ...

May 8, 2025  0

Comments

Name

Email

Comment

Post Comment